Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Enhancer-gene specificity in development and disease

  • Pachano, Tomás
  • Haro Gabicagogeascoa, Endika|||0000-0002-0229-6365
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
Enhancers control the establishment of spatiotemporal gene expression patterns throughout development. Over the past decade, the development of new technologies has improved our capacity to link enhancers with their target genes based on their colocalization within the same topological domains. However, the mechanisms that regulate how enhancers specifically activate some genes but not others within a given domain remain unclear. In this Review, we discuss recent insights into the factors controlling enhancer specificity, including the genetic composition of enhancers and promoters, the linear and 3D distance between enhancers and their target genes, and cell-type specific chromatin landscapes. We also discuss how elucidating the molecular principles of enhancer specificity might help us to better understand and predict the pathological consequences of human genetic, epigenetic and structural variants., Work in the Rada-Iglesias laboratory is funded by the Ministerio de Ciencia e Innovación and the Agencia Españ ola de Investigación; by the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancer-gene specificity in development and disease

  • Pachano, Tomás
  • Haro, Endika
  • Rada-Iglesias, Álvaro
Enhancers control the establishment of spatiotemporal gene expression patterns throughout development. Over the past decade, the development of new technologies has improved our capacity to link enhancers with their target genes based on their colocalization within the same topological domains. However, the mechanisms that regulate how enhancers specifically activate some genes but not others within a given domain remain unclear. In this Review, we discuss recent insights into the factors controlling enhancer specificity, including the genetic composition of enhancers and promoters, the linear and 3D distance between enhancers and their target genes, and cell-type specific chromatin landscapes. We also discuss how elucidating the molecular principles of enhancer specificity might help us to better understand and predict the pathological consequences of human genetic, epigenetic and structural variants., Work in the Rada-Iglesias laboratory is funded by the Ministerio de Ciencia e Innovación and the Agencia Española de Investigación; by the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protocol to study sufficiency of cis-regulatory elements in mouse embryonic stem cells using a CRISPR-mediated knockin approach

  • Pachano, Tomás
  • Rada-Iglesias, Álvaro
Cis-regulatory elements (CREs) orchestrate the spatiotemporal control of gene expression. The regulatory activity of CREs is typically assessed by reporter assays, in which CREs are studied outside their endogenous context. To circumvent this problem, we developed a CRISPR-Cas9 knockin approach to study CREs in a scar-free genomic context. Here, we describe the design, transfection, and screening protocol to insert CREs in mouse embryonic stem cells. Our strategy can provide important insights into the sufficiency of CREs for gene expression control., Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme, grant PGC2018-095301-B-I00 funded by MCIN/AEI /10.13039/501100011033 and by “ERDF A way of making Europe,” grant RED2018-102553-T (REDEVNEURAL 3.0) funded by MCIN/AEI /https://doi.org/10.13039/501100011033, grant ERC CoG “PoisedLogic” (862022) funded by the European Research Council, and grant “ENHPATHY” H2020-MSCA-ITN-2019-860002 funded by the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Current challenges in understanding the role of enhancers in disease

  • Zaugg, Judith Barbara
  • Sahlén, Pelin
  • Andersson, Robin
  • Alberich-Jorda, Meritxell
  • Laat, Wouter de
  • Deplancke, Bart
  • Ferrer, Jorge
  • Mandrup, Susanne
  • Natoli, Gioacchino
  • Plewczynski, Dariusz
  • Rada-Iglesias, Álvaro
  • Spicuglia, Salvatore
Enhancers play a central role in the spatiotemporal control of gene expression and tend to work in a cell-type-specific manner. In addition, they are suggested to be major contributors to phenotypic variation, evolution and disease. There is growing evidence that enhancer dysfunction due to genetic, structural or epigenetic mechanisms contributes to a broad range of human diseases referred to as enhanceropathies. Such mechanisms often underlie the susceptibility to common diseases, but can also play a direct causal role in cancer or Mendelian diseases. Despite the recent gain of insights into enhancer biology and function, we still have a limited ability to predict how enhancer dysfunction impacts gene expression. Here we discuss the major challenges that need to be overcome when studying the role of enhancers in disease etiology and highlight opportunities and directions for future studies, aiming to disentangle the molecular basis of enhanceropathies., All authors are members of the EU-funded Innovative Training Network ‘Molecular Basis of Human Enhanceropathies’ (Enhpathy, www.enhpathy.eu) and received funding from the Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 860002., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

  • Asenjo, Helena G.
  • Alcazar-Fabra, María
  • Espinosa-Martínez, Mencía
  • López-Onieva, Lourdes
  • Gallardo, Amador
  • Dimitrova, Emilia
  • Feldmann, Angelika
  • Pachano, Tomás
  • Martorell-Marugán, Jordi
  • Carmona-Sáez, Pedro
  • Sanchez-Pozo, Antonio
  • Rada-Iglesias, Álvaro
  • Klose, Robert J.
  • Landeira, David
The potential of pluripotent cells to respond to developmental cues and trigger cell differentiation is enhanced during the G1 phase of the cell cycle, but the molecular mechanisms involved are poorly understood. Variations in polycomb activity during interphase progression have been hypothesized to regulate the cell-cycle-phase-dependent transcriptional activation of differentiation genes during lineage transition in pluripotent cells. Here, we show that recruitment of Polycomb Repressive Complex 1 (PRC1) and associated molecular functions, ubiquitination of H2AK119 and three-dimensional chromatin interactions, are enhanced during S and G2 phases compared to the G1 phase. In agreement with the accumulation of PRC1 at target promoters upon G1 phase exit, cells in S and G2 phases show firmer transcriptional repression of developmental regulator genes that is drastically perturbed upon genetic ablation of the PRC1 catalytic subunit RING1B. Importantly, depletion of RING1B during retinoic acid stimulation interferes with the preference of mouse embryonic stem cells (mESCs) to induce the transcriptional activation of differentiation genes in G1 phase. We propose that incremental enrolment of polycomb repressive activity during interphase progression reduces the tendency of cells to respond to developmental cues during S and G2 phases, facilitating activation of cell differentiation in the G1 phase of the pluripotent cell cycle., The Landeira lab is supported by the Spanish ministry of science and innovation (PID2019-108108-100, EUR2021-122005), the Andalusian regional government (PIER-0211-2019, PY20_00681) and the University of Granada (A-BIO-6-UGR20) grants. Research in the Klose lab is supported by the Wellcome Trust (209400/Z/17/Z) and the European Research Council (681440). A.F. was supported by a Sir Henry Wellcome Post-doctoral fellowship (110286/Z/15/Z). Work in the Rada-Iglesias lab is funded by the Ministerio de Ciencia e Innovación, the Agencia Española de Investigación and the European Regional Development Fund (PGC2018-095301-B-I00 and RED2018-102553-T); by the European Research Council (862022); and by the European Commission (H2020-MSCA-ITN-2019-860002)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

POSTRE: A tool to predict the pathological effects of human structural variants

  • Sánchez-Gaya, Víctor
  • Rada-Iglesias, Álvaro
Understanding the pathological impact of non-coding genetic variation is a major challenge in medical genetics. Accumulating evidences indicate that a significant fraction of genetic alterations, including structural variants (SVs), can cause human disease by altering the function of non-coding regulatory elements, such as enhancers. In the case of SVs, described pathomechanisms include changes in enhancer dosage and long-range enhancer-gene communication. However, there is still a clear gap between the need to predict and interpret the medical impact of non-coding variants, and the existence of tools to properly perform these tasks. To reduce this gap, we have developed POSTRE (Prediction Of STRuctural variant Effects), a computational tool to predict the pathogenicity of SVs implicated in a broad range of human congenital disorders. By considering disease-relevant cellular contexts, POSTRE identifies SVs with either coding or long-range pathological consequences with high specificity and sensitivity. Furthermore, POSTRE not only identifies pathogenic SVs, but also predicts the disease-causative genes and the underlying pathological mechanism (e.g, gene deletion, enhancer disconnection, enhancer adoption, etc.)., Víctor Sánchez-Gaya is supported by a doctoral fellowship from the University of Cantabria (Spain); Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme [PGC2018-095301-B-I00, PID2021-123030NB-I00] funded by MCIN/AEI/10.13039/501 100 011 033 and by ‘ERDF A way of making Europe’ [RED2018-102553-T (REDEVNEURAL 3.0)] funded by MCIN/AEI/10.13039/501 100 011 033; ERC CoG ‘PoisedLogic’ [862 022] funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The interaction between enhancer variants and environmental factors as an overlooked aetiological paradigm in human complex disease

  • Robert, Sarah
  • Rada-Iglesias, Álvaro
The interactions between genetic and environmental risk factors contribute to the aetiology of complex human diseases. Genome-wide association studies (GWAS) have revealed that most of the genetic variants associated with complex diseases are located in the non-coding part of the genome, preferentially within enhancers. Enhancers are distal cis-regulatory elements composed of clusters of transcription factors binding sites that positively regulate the expression of their target genes. The generation of genome-wide maps for histone marks (e.g., H3K27ac), chromatin accessibility and transcription factor and coactivator (e.g., p300) binding profiles have enabled the identification of enhancers across many human cell types and tissues. Nonetheless, the functional and pathological consequences of the majority of disease-associated genetic variants located within enhancers seem to be rather minor under normal conditions, thus questioning their medical relevance. Here we propose that, due to the prevalence of enhancer redundancy, the pathological effects of many disease-associated non-coding genetic variants might be preferentially (or even only) manifested under environmental stress., Sarah Robert is supported by ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002. Work in the Rada-Iglesias laboratory is supported by grants PID2021-123030NB-I00 funded by MCIN/AEI/10.13039/501100011033, grant ERC CoG ‘PoisedLogic’ (862022) funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Understanding enhancer function to understand human disease

  • Spicuglia, Salvatore
  • Rada-Iglesias, Álvaro
In multicellular organisms, spatial and temporal regulation of gene expression is crucial for development, cellular differentiation, and homeostasis. Cell-type-specific regulation of gene expression is achieved through the interaction between regulatory elements that are either proximal (promoters) or distal (enhancers, silencers, insulators) to gene transcription start sites (TSSs). Enhancers, which primarily function in a cell type-specific manner, are short (100–1000 bp) DNA sequences that contain binding sites for transcription factors and increase the expression of their target genes in cis. Four decades after their first discovery, enhancers are now widely considered key elements in the spatiotemporal control of gene expression underlying human development and homeostasis. Furthermore, enhancers play a significant role in disease, evolution, and phenotypic diversity. From a medical point of view, accumulating evidence indicate that a wide spectrum of human disorders, known as enhanceropathies, are influenced by enhancer malfunction caused by genetic, structural, or epigenetic alterations. These processes can directly cause cancer or Mendelian disorders, while they can also underpin the susceptibility to many common diseases. Despite recent advances in our understanding of enhancer biology and function, our capacity to foresee how enhancer dysfunction affects gene expression and, thus, human disease, is still limited. Therefore, elucidating the molecular basis of enhancer function in healthy and disease states has far-reaching translational implications, as it can help improving the diagnosis and therapeutic intervention of a broad range of human disorders., The preparation of the special issue has been done with the support of the “Enhpathy” Marie Sklodowska-Curie actions (MSCA)—Innovative Training Network (ITN) funded by the European Union's Horizon 2020 research and innovation program (Grant Number: 860002).
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Dual role of ZIC2 during neural induction: from priming transcription factor to enhancer activator

  • Mariner Faulí, María
  • Sánchez Gaya, Víctor
  • Robert, Sarah Malika
  • Respuela Alonso, Patricia
  • Cruz Molina, Sara de la
  • Lobato-moreno, Sara
  • Trovato, Matteo
  • Prummel, Karin D.
  • Noh, Kyung-Min
  • Zaugg, Judith B.
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
Defects in ZIC2, a member of the Zinc Finger of the Cerebellum family of transcription factors (TFs), cause holoprosencephaly, a congenital brain malformation characterized by the defective cleavage of cerebral hemispheres. However, the gene regulatory network (GRN) controlled by ZIC2 during neural development remains largely unexplored. Here, we combined a mouse embryonic stem cell (mESC) in vitro differentiation model toward anterior neural progenitors with genome editing and genomic methods to elucidate the ZIC2 GRN. We found that ZIC2 is dispensable in mESC due to compensation by ZIC3. In contrast, during neural induction ZIC2 directly controls the expression of master regulators implicated in the patterning and morphogenesis of specific brain regions (e.g. midbrain and roof plate). Mechanistically, ZIC2 plays a dual role in neural differentiation: during pluripotency exit, ZIC2 binds de novo to distal enhancers and increases their chromatin accessibility; during neural induction, ZIC2 is essential for the activation of a subset of the previously primed enhancers, which in turn control the expression of neural patterning regulators and signalling pathways (i.e. WNT) that prevent premature neuronal differentiation. Therefore, by sequentially acting as a promiscuous priming TF and selective enhancer activator, ZIC2 canalizes pluripotent cells toward neural progenitors with rostro-dorsal identities., M.M.F. acknowledges the support of the EMBO Scientific Exchange Grant, which funded her internship at EMBL Heidelberg during which the single-cell multiomic data were generated. M.M.F. PhD was supported by a Grant for Pre-doctoral Contracts for the Training of Researchers – FPI National Subprogram for Training (Ref: PRE2019- 089037). Work in the Rada-Iglesias laboratory is supported by the following grants: PID2021-123030NB-I00 (AR-I), funded by MCIN/AEI/10.13039/501100011033 and by ERDF “A way of making Europe”; RED2022- 134100-T (AR-I) (REDEVNEURAL 3.0), funded by MCIN/AEI/10.13039/501100011033; ERC Consolidator Grant PoisedLogic (862022) (AR-I), funded by the European Research Council; ENHPATHY H2020-MSCAITN-2019–860002 (AR-I), funded by the European Commission; and Chromrare HORIZON- MSCA-2021-DN01–101073334 (AR-I), also funded by the European Commission. Funding to pay the Open Access publication charges for this article was provided by the European Research Council Consolidator grant.
UCrea Repositorio Abierto de la Universidad de Cantabria
Publicación Artículo científico (JournalArticle)

Cooperative insulation of regulatory domains by CTCF-dependent physical insulation and promoter competition

  • Ealo Rodríguez, Thais
  • Sánchez Gaya, Víctor
  • Respuela Alonso, Patricia
  • Muñoz San Martín, María |||0000-0002-7249-5343
  • Martín-Batista, Elva
  • Haro Gabicagogeascoa, Endika|||0000-0002-0229-6365
  • Rada Iglesias, Álvaro|||0000-0001-7137-1341
The specificity of gene expression during development requires the insulation of regulatory domains to avoid inappropriate enhancer-gene interactions. In vertebrates, this insulator function is mostly attributed to clusters of CTCF sites located at topologically associating domain (TAD) boundaries. However, TAD boundaries allow some physical crosstalk across regulatory domains, which is at odds with the specific and precise expression of developmental genes. Here we show that developmental genes and nearby clusters of CTCF sites cooperatively foster the robust insulation of regulatory domains. By genetically dissecting a couple of representative loci in mouse embryonic stem cells, we show that CTCF sites prevent undesirable enhancer-gene contacts (i.e. physical insulation), while developmental genes preferentially contribute to regulatory insulation through non-structural mechanisms involving promoter competition rather than enhancer blocking. Overall, our work provides important insights into the insulation of regulatory domains, which in turn might help interpreting the pathological consequences of certain structural variants., Acknowledgements: We would like to thank all the Rada-Iglesias lab members for insightful comments and suggestions. Work in the Rada-Iglesias laboratory is supported by grant PID2021-123030NB-I00 (AR-I) funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF A way of making Europe, grant RED2022-134100-T (AR-I) (REDEVNEURAL 3.0) funded by MCIN/AEI /10.13039/501100011033, grant ERC CoG PoisedLogic (862022) (A.R.-I.) funded by the European Research Council, grant ENHPATHY H2020-MSCA-ITN-2019-860002 (A.R.-I.) funded by the European Commission, grant Chrom_rare HORIZON-MSCA-2021-DN-01-101073334 (A.R.-I.) funded by the European Commission. E.M.B was granted with a fellowship from the network PIE-202120E047-Conexiones-Life.